That's important, because the way a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and be efficient. To put it simply, we have to know how these proteins fold if we want a drug to work. Historically, this has been an experimental procedure (jeff brown 1 biotech company). Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much easier to create drugs that do what they're designed to do. This was an advancement nearly nobody noticed. However it's going to have extensive ramifications for treating illness. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be plenty of investment opportunities in this space, too. Moving subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (self-driving cars). That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be surprised if it drew back maybe significantly before going greater - tech stocks. I've been covering bitcoin for a long time now. Among the first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I entitled my report "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time. We were mainly informing readers. However that's not the big concern anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So think about that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a huge factor I'm bullish on it this year. diplomatic relations. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are numerous excellent private companies on the edge of hitting the general public markets And I've been dealing with a new way for you to invest even before these companies go public.
This opportunity has actually been building over the last few years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the information. Go right here to reserve your spot for totally free.
Emma Walsh here, managing editor of the Journal. Routine Diary readers know that tech isn't our normal beat (the legacy report prediction). And when it concerns tech investing, we leave it to the professionals. Luckily, we have several such specialists in our Rolodex. Our coworker Jeff Brown will recognize to our longtime readers. He is among the most accomplished tech investing specialists we understand (jeff brown genome sequencing). In reality, he had numerous triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take an appearance at the big photo and forecast what's just around the corner.
That consists of things like 5G networks, biotech, expert system, and a lot more. These trends are experiencing exponential development and developing amazing chances for investors. I wish to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. jeff brown stock predictions 2021. But regardless of what many readers might think, this is a trend that's just getting going. Despite the fact that the COVID-19 pandemic interfered with supply chains last year, a remarkable 250 million 5G-enabled gadgets were still offered.
And all of this eventually led to Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown genome sequencing). Losing two months of production and sales actually affects how lots of 5G devices are offered in the fiscal year. When you consider all of that, offering 250 million systems is remarkable. More importantly, the delays triggered by the pandemic produced a lots of bottled-up demand. And that demand is now going to be pressed into 2021. In reality, I predict that more than 500 million 5G devices will be delivered in 2021 - artificial intelligence. And that's not my only 5G forecast When I've talked about 5G in the past, I've explained its three various phases.
In Phase Two, 5G devices go on sale. 5G phones and other products begin to reach customers. And in Stage 3, 5G services start to be used (diplomatic relations). That's when we start to see applications operating on 5G networks. Think about things like huge multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Stage Three by this summer season. This starts something of a virtuous cycle: A lot of people don't actually appreciate the innovation. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That leads to more 5G apps being developed. In fact, 5G is going to open a suite of extraordinary applications: self-driving automobiles, the Web of Things, robotic surgery, and more. All of these technologies require 5G. The investment opportunities going forward will be huge. Stepping far from 5G, the next essential technology I foresee in 2021 is CRISPR hereditary modifying. CRISPR represents "clustered regularly interspaced short palindromic repeat." It's a mouthful. But it's one of the most amazing developments in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software application.
The program can crash or not function properly. CRISPR uses a comparable concept but with our genetic code. "Typos" in our genome can lead to disease. CRISPR can remedy these "typos." For years, CRISPR was mostly a specific niche technology that wasn't well understood. And during that time, there were really only three business operating in this space. However things are altering. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're treating diseases and seeing that this technology just works. And as a result, a "second crop" of early-stage CRISPR companies is going public and delivering extraordinary returns. This whole market is efficiently a greenfield chance.
There's space for numerous companies to exist in this area. black sea. And there will be more. That's my prediction for CRISPR in 2021. I forecast that 2 or three more hereditary editing business will hold their IPOs. Sticking to biotechnology, we are seeing amazing things occurring at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its latest Alpha, Fold software can precisely predict the folding of a protein based exclusively on its amino acid sequence with 92. 4% accuracy. That's important because the way a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be effective.
Historically, this has been an experimental procedure. Now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much simpler to produce drugs that do what they're created to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however numerous drug treatments produced utilizing this innovation. This was among those advancements that practically no one discovered. But it's going to have extensive ramifications for curing disease. And, naturally, there will be lots of investment chances in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be surprised if it drew back perhaps substantially prior to going greater. I have actually been covering bitcoin for a very long time now. Among the very first research reports I ever published was on bitcoin - brownstone research. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my recommendation. But at the time of that initial suggestion, I titled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
However nobody is asking that concern any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. korean actress. Mass, Mutual is a 150-year-old organization. So think of that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus offer prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and declares the information depends on date since February 2021, however we could not individually verify this claim. Offered Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down an accurate figure at this moment. Brown is best understood for his sage-like capability to pick winning technology stocks. He spent more than 25 years investigating technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience offers him an excellent perspective on the market. He's constantly on the hunt for brand-new opportunities, and he shares a lot of his best choices in the Future Report.
That's full marks, however it's not absurdly reasoned. Brown has an excellent reputation as a stock-picker, and he effectively predicted a few of the greatest economic occasions of the previous 20 years. Although he does not appear to release his picks to the general public, the service's success is a direct indication of Brown's stock-picking expertise. Nobody on Wall Street gets it right whenever, but Jeff Brown's accurate forecasts have earned him legions of dedicated followers. That states a lot about his ability. The Future Report is released by Brownstone Research, a popular monetary research publisher. Brownstone Research provides numerous research services with a wide range of expertises - jeff brown 2020 predictions.
The company is likewise connected with Bonner & Partners, another well-respected research publisher - jeff brown genome sequencing stock. On its site, Brownstone states its mission is to provide retail investors with professional-grade research study: "For too long, the best financial investment research study has not been available to private financiers. It has been typically reserved for financial investment banks, hedge funds, private equity, and high-net-worth clients. legacy report prediction. The objective of Brownstone Research is to make that sort of exclusive research study offered to any financiers wanting to get an edge in the marketplaces. The objective is simple to provide distinct and successful investment research discovered no place else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research, and he also serves as the company's Chief Investment Expert.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to use its clients. After years of steady success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a family name throughout the majority of America. If you understand even a little bit about the market, you understand that he has a track record as a King Midas of sorts. self-driving cars. Whatever he touches relies on gold! Jeff is aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big project.
In fact, Brown believes S.A.V. biotech stocks. might be "the greatest trend of the 2020s, and he's not alone. Have a look at these quotes from other popular S.A.V. bulls: Elon's next big act will be weding two advanced innovations: expert system and electric cars. Musk hopes the combination will help him develop the very first fully-autonomous, self-driving cars ever. It's nothing except the vehicle industry's Holy Grail. As you understand, electrical automobiles and self-driving cars and truck stocks have been big this year, however the Wall Street device has actually approved hype without much concrete outcome. Regardless of a drastic boost in competition over the past few years, Brown still thinks Musk has the very best opportunity of putting everything together.
tech could be the magic string that connects all of it together. S.A.V. represents Shared Autonomous Car, and it might be the future of transport. Generally, this technology would enable you to lease out your vehicle as a self-governing, self-driving taxi when you're not using it. You merely leave the automobile and press a button on an app that informs the vehicle to "sign up with the fleet." Next thing you understand, you're relaxing on your sofa while your automobile shuttles ride-sharers around town. Most importantly, you get to keep a significant portion of the profits. It sounds ridiculous, but it might be closed than you think.